Protagonist Therapeutics (NASDAQ:PTGX) reported quarterly losses of $(0.64) per share. This is a 8.57 percent increase over losses of $(0.70) per share from the same period last year.
Related Posts
Delta Air Lines Shares Fall On Mixed Outlook; Q4 Earnings Exceed Expectations
Delta Air Lines Inc (NYSE:DAL) reported a fourth-quarter FY22 adjusted operating revenue growth of 8% from Q4 FY19 to $12.3 billion,…
Recap: Marathon Oil Q1 Earnings
Marathon Oil (NYSE:MRO) reported its Q1 earnings results on Wednesday, May 3, 2023 at 04:30 PM. Here’s what…
Analyzing Broadcom In Comparison To Competitors In Semiconductors & Semiconductor Equipment Industry
In the fast-paced and cutthroat world of business, conducting thorough company analysis is essential for investors and industry…